CBD Therapy
Withdrawn from the US market on 8 July 2024 (according to the DSLD)
MC4MS Medical Cannabis for Multiple Sclerosis, food supplement from the US market
Label withdrawn from the US market. CBD Therapy (MC4MS Medical Cannabis for Multiple Sclerosis), a food supplement without a usable barcode in DSLD, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- MC4MS Medical Cannabis for Multiple Sclerosis
- Barcode
- Not provided or invalid in DSLD
- Form
- Liquid
- One serving
- 1 ml
- Servings
- number of servings per day not stated
- Other ingredients (in English, as written)
- Stalk Hemp CO2 Extracted oil, organic Hemp seed Oil
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Calories | Other | 8 Calorie(s) |
| Calories from Fat | Other | 8 Calorie(s) |
| Total Fat | Fat | 1 Gram(s) |
| Omega 3 & 6 | Blend | 3 Gram(s) |
| Hemp Oil | Fat | 16.7 mg |
| Hemp extract (Cannabis sativa) | Plant | 10 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : MC4MS Medical Cannabis for Multiple Sclerosis
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “CBD Therapy : étiquette retirée du marché américain (MC4MS Medical Cannabis for Multiple Sclerosis): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/dsld-221089-cbd-therapy-mc4ms-medical-cannabis-for-multiple-sclerosis, updated 8 July 2024.